Synco Research Solutions has supported many clinical studies in the Central Nervous System therapeutic area, such as Alzheimer’s, Parkinson’s, and Infectious Diseases studies across Phases I to III.

Synco Research Solutions has worked in a number of studies in the indications of Acne, Dermatitis, Atopic Eczema, Acne Vulgaris, Psoriasis Lesions, and Lipodystrophy. Endpoints include numbers of different types of lesions/pustules.

Synco Research Solutions has worked in a number of different indications in the oncology area indicating squamous cell cancer (various locations) and solid organ cancers including prostate. We are familiar with many of the key endpoints that arise including assessing tumour response (lesion size and other methods of tumour measurement), progression-free survival, and overall survival, and we have undertaken studies modelling tumour growth.

Synco Research Solutions has worked in a number of studies in the indications of Crohn’s disease, Ulcerative Colitis and constipation.

Synco Research Solutions has worked on multiple studies in Hematology covering studies on Phase I and IV.

We have successfully worked on numerous Infectious Diseases (including Phase III studies in this area). Example indications include; Cholera, influenza, and Hepatitis. In addition, we have a long-established history of supporting our customers on HIV studies across a range of compounds and indications. We are familiar with a range of endpoints, including quality of life (QoL) data, viral-load, clusters of differentiation 4 (CD4) counts, and survival analysis. We have experience in detailed evaluation of the impact of genetic variants on safety and efficacy endpoints.

Synco Research Solutions has successfully worked on a number of multi-center, flexible dose, and multinational studies across the pain therapeutic area (e.g. post-surgical pain after inguinal hernia repair, neuropathic pain associated with HIV neuropathy, and chronic central neuropathic pain after spinal cord injury).

Synco Research Solutions has worked in a number of studies in the indications of Type 2 Diabetes and Obesity.

Synco Research Solutions has worked in a number of different indications in the neurosciences area, including Major Depressive Disorder, Attention-Deficit-Hyperactivity-Disorder, Alzheimer’s Disease, Parkinson’s Disease, Huntingdon Disease, Schizophrenia, Pain (acute pain, arthritic pain, diabetic peripheral neuropathic pain, post-herpetic neuralgia, fibromyalgia), restless legs syndrome, and migraine. Challenges in the neurosciences area include high placebo response in some indications, monitoring of suicidal ideation and behaviour, assessment of symptoms that emerge on discontinuation of treatment, and carrying out studies in subjects with significant cognitive impairment.

Synco Research Solutions has worked in a number of different indications in the respiratory and immuno-inflammatory disease area including allergic rhinitis, asthma, COPD (Chronic Obstructive Pulmonary Disease).